“Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations”

Nova Biomedical* presents… “Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations” Part I: Clinical Consequences  |  “Venous, arterial, and now capillary specimens are all FDA cleared for testing […]